Liminatus Pharma, Inc. (Nasdaq: LIMN) ('Liminatus” or the 'Company”) today announced that the Company received a delisting ...
Sacituzumab tirumotecan (sac-TMT)(佳泰莱®) plus pembrolizumab versus pembrolizumab as first-line treatment for PD-L1 positive advanced NSCLC: Results from the randomized, controlled, registrational Phase ...
Purecore Metals Inc. (CSE: PURE) ('Purecore” or the 'Company”) is pleased to announce that it has engaged HEG & Associates ...
Last Patient In enrolled ahead of schedule; interim analysis anticipated by year-end 2026 to inform plans for the next stage ...
Award marks Rocket Lab's first satellite production program for geostationary orbit and continues a Space Systems Command ...
Mason Street Wealth Management, a leading financial services firm specializing in retirement planning, highlights its innovative vision-first financial strategy, designed to help individuals ...
Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical ...
HUTCHMED (China) Limited ('HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new and updated data from several studies of compounds discovered by HUTCHMED will be presented at the American ...
Hofseth BioCare ASA ('HBC”) has entered into an Exclusive License and Supply Agreement (the 'Agreement”) with Fission Holdings LLC ('Fission”), a US-based affiliate and sales channel operator ...
FortuneX Acquisition Corporation, a blank check company incorporated in the Cayman Islands as an exempted company (the 'Company”), today announced the pricing of its initial public offering ('IPO”) of ...
A multi-year partnership centered on 'Ultimate Connection” through music, technology, and unforgettable live experiences ...
Wilton Kee incoming Chief Executive Officer, Manulife Hong Kong and Macau "Wilton's appointment underscores our continued ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results